Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06299137Phase 1Completed
Phase 1, randomised trial of ropivacaine in acute pain and rib fracture (2 arms), sponsored by Rhode Island Hospital. Primary endpoint: Pain, Incentive Spirometry, and Cough Ability Score at 5 hours. Started Jul 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06299137.